Startseite Medizin Clinical utility of stimulation tests in infants with suspected adrenal insufficiency (AI)
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Clinical utility of stimulation tests in infants with suspected adrenal insufficiency (AI)

  • Preneet Cheema Brar ORCID logo EMAIL logo
Veröffentlicht/Copyright: 22. April 2019

Abstract

Diagnosis of adrenal insufficiency (AI) in infants can be difficult. While a low random cortisol can signal AI, often confirmatory tests are required when clinical suspicion is strong but the cortisol levels are equivocal. Several studies have demonstrated that in sick preterm infants, there is relative adrenal insufficiency (RAI) defined as an inadequate cortisol production relative to the degree of stress or illness, a condition which can last for several weeks, while in term infants the adrenal axis is mature at birth (Bagnoli F, Mori A, Fommei C, Coriolani G, Badii S, et al. ACTH and cortisol cord plasma concentrations in preterm and term infants. J Perinatol 2013;33:520–4). Adrenocorticotrophic hormone (ACTH) and corticotrophin releasing hormone (CRH) stimulation tests have been validated in infants in several studies. In light of recent reports of false-negative results of stimulation tests, it is imperative to highlight the pitfalls of these tests. The purpose of this communication is to bring attention to the accuracy of timing of these tests in infants.


Corresponding author: Preneet Cheema Brar, MD, MSCE, Hassenfeld Childrens’ Hospital, Division of Pediatric Endocrinology and Diabetes, New York University School of Medicine, 135 E 31st street, L-2, New York 10016-6402, NY, USA, Phone: +212-263-5940, Fax: +212-263-5808,

  1. Author contributions: The author accepts responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Ryabets-Lienhard A, Stewart C, Borchert M, Geffner ME. The optic nerve hypoplasia spectrum: review of the literature and clinical guidelines. Adv Pediatr 2016;63:127–46. 10.1016/j.yapd.2016.04.009Suche in Google Scholar PubMed

2. Bagnoli F, Mori A, Fommei C, Coriolani G, Badii S, et al. ACTH and cortisol cord plasma concentrations in preterm and term infants. J Perinatol 2013;33:520–4.10.1038/jp.2012.165Suche in Google Scholar PubMed

3. Mesiano S, Jaffe RB. Developmental and functional biology of the primate fetal adrenal cortex. Endocrine Rev 1997;18:378–403.Suche in Google Scholar

4. de Moraes DC, Vaisman M, Conceicao FL, Ortiga-Carvalho TM. Pituitary development: a complex, temporal regulated process dependent on specific transcriptional factors. J Endocrinol 2012;215:239–45.10.1530/JOE-12-0229Suche in Google Scholar PubMed

5. Couture C, Saveanu A, Barlier A, Carel JC, Fassnacht M, et al. Phenotypic homogeneity and genotypic variability in a large series of congenital isolated ACTH-deficiency patients with TPIT gene mutations. J Clin Endocrinol Metab 2012;97:E486–95.10.1210/jc.2011-1659Suche in Google Scholar PubMed

6. Shi C, Wang F, Tong A, Zhang XQ, Song HM, et al. NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency: a case report and review of literature. Medicine (Baltimore) 2016;95:e5081.10.1097/MD.0000000000005081Suche in Google Scholar PubMed PubMed Central

7. Jackson RS, Creemers JW, Farooqi IS, Raffin-Sanson ML, Varro A, et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest 2003;112:1550–60.10.1172/JCI200318784Suche in Google Scholar PubMed

8. Niwa F, Kawai M, Kanazawa H, Iwanaga K, Matsukura T, et al. Limited response to CRH stimulation tests at 2 weeks of age in preterm infants born at less than 30 weeks of gestational age. Clin Endocrinol (Oxf) 2013;78:724–9.10.1111/cen.12049Suche in Google Scholar PubMed

9. Iwata O, Okamura H, Saitsu H, Saikusa M, Kanda H, et al. Diurnal cortisol changes in newborn infants suggesting entrainment of peripheral circadian clock in utero and at birth. J Clin Endocrinol Metab 2013;98:E25–32.10.1210/jc.2012-2750Suche in Google Scholar PubMed

10. Bourchier D. Validity of ACTH stimulation test. Australian Paediatr J 1988;24:157.10.1111/j.1440-1754.1988.tb00310.xSuche in Google Scholar PubMed

11. Abdu TA, Elhadd TA, Neary R, Clayton RN. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 1999;84:838–43.10.1210/jcem.84.3.5535Suche in Google Scholar PubMed

12. Grinspoon SK, Biller BM. Clinical review 62: Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994;79:923–31.10.1210/jcem.79.4.7962298Suche in Google Scholar PubMed

13. Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016;10:364–89.10.1210/jc.2015-1710Suche in Google Scholar PubMed PubMed Central

14. Dorin RI, Qualls CR, Crapo LM. Diagnosis of adrenal insufficiency. Ann Int Med 2003;139:194–204.10.7326/0003-4819-139-3-200308050-00009Suche in Google Scholar PubMed

15. Thaler LM, Blevins LS, Jr. The low dose (1-microg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. J Clin Endocrinol Metab 1998;83:2726–9.10.1210/jcem.83.8.5039Suche in Google Scholar PubMed

16. Schmidt IL, Lahner H, Mann K, Petersenn S. Diagnosis of adrenal insufficiency: evaluation of the corticotropin- releasing hormone test and basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease. J Clin Endocrinol Metab 2003;88:4193–8.10.1210/jc.2002-021897Suche in Google Scholar PubMed

17. Ng PC, Lam CW, Lee CH, Ma KC, Fok TF, et al. Reference ranges and factors affecting the human corticotropin-releasing hormone test in preterm, very low birth weight infants. J Clin Endocrinol Metab 2002;87:4621–8.10.1210/jc.2001-011620Suche in Google Scholar PubMed

18. Ng PC, Lee CH, Lam CW, Ma K, Fok T, et al. Transient adrenocortical insufficiency of prematurity and systemic hypotension in very low birthweight infants. Arch Dis Childhood Fetal Neonatal Ed 2004;89:F119–26.10.1136/adc.2002.021972Suche in Google Scholar PubMed PubMed Central

19. Karlsson R, Kallio J, Irjala K, Ekblad S, Toppari J, et al. Adrenocorticotropin and corticotropin-releasing hormone tests in preterm infants. J Clin Endocrinol Metab 2000;85:4592–5.10.1210/jc.85.12.4592Suche in Google Scholar PubMed

20. Coshway LK, Indyk JA, Bowden SA. Repeating ACTH stimulation test is necessary to diagnose ACTH deficiency in neonatal hypopituitarism with initial false negative result. Global Pediatr Health 2014;1. PMID: 2733592810.1177/2333794X14563385Suche in Google Scholar PubMed PubMed Central

Received: 2018-08-04
Accepted: 2019-02-07
Published Online: 2019-04-22
Published in Print: 2019-05-27

©2019 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Reviews
  3. Using height-corrected definition of metabolic syndrome in children and adolescents
  4. Association between early antibiotic exposure and risk of childhood weight gain and obesity: a systematic review and meta-analysis
  5. Original Articles
  6. Carbonated beverage consumption is associated with lower C-peptide in adolescents
  7. Low levels of cardiorespiratory fitness and abdominal resistance are associated with metabolic risk in schoolchildren
  8. Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
  9. Obesity-related thyroiditis in childhood: relationship with insulin resistance
  10. An isolated Xp deletion is linked to autoimmune diseases in Turner syndrome
  11. Non-invasive assessment of aortic stiffness and blood pressure in young Turner syndrome patients
  12. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening
  13. The “combined team” transition clinic model in endocrinology results in high adherence rates and patient satisfaction
  14. Utilizing health information technology to improve the recognition and management of life-threatening adrenal crisis in the pediatric emergency department: medical alert identification in the 21st century
  15. Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia: 6 years of follow-up
  16. Letter to the Editor
  17. Growth failure in infancy and early adiposity rebound
  18. Short Communication
  19. Clinical utility of stimulation tests in infants with suspected adrenal insufficiency (AI)
  20. Case Reports
  21. Two siblings with Gaucher type 3c: different clinical presentations
  22. Acquired partial lipodystrophy with metabolic disease in children following hematopoietic stem cell transplantation: a report of two cases and a review of the literature
  23. Therapeutic challenges in a patient with the simple virilizing (SV) form of congenital adrenal hyperplasia (CAH) due to the P30L/I172N genotype
Heruntergeladen am 19.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2019-0025/pdf
Button zum nach oben scrollen